B-cell receptor recognizing meningococcal capsular polysaccharide epitopes (BCR-MCPS)

The B-cell receptor (BCR) recognizing meningococcal capsular polysaccharide epitopes is a membrane-bound immunoglobulin complex located on the surface of B lymphocytes. Its primary biological function is the specific recognition and binding of the capsular polysaccharides of Neisseria meningitidis, which are the major virulence factors and primary targets for protective immunity against meningococcal disease. Upon binding to these epitopes, the BCR initiates intracellular signaling cascades that lead to B-cell activation, proliferation, and differentiation into plasma cells that secrete protective antibodies (IgG and IgM) and memory B cells. In the context of clinical medicine and pharmacology, this receptor is the functional target of meningococcal vaccines. Conjugate vaccines are specifically designed to engage these BCRs while recruiting T-cell help to overcome the T-cell independent nature of pure polysaccharide antigens, thereby inducing long-term immunological memory. The interaction between the vaccine antigens and these specific BCRs is critical for preventing invasive meningococcal infections, including meningitis and septicemia, by ensuring the production of antibodies that facilitate complement-mediated killing and opsonophagocytosis of the pathogen.

Other names

Meningococcal polysaccharide-specific B-cell receptorAnti-meningococcal capsular polysaccharide BCRNeisseria meningitidis polysaccharide-binding B-cell receptorSurface immunoglobulin recognizing meningococcal capsular antigens

Vaccine antigens bind to the specific B-cell receptor (BCR), triggering receptor-mediated endocytosis, antigen processing, and presentation to T-cells, which leads to B-cell clonal expansion and the secretion of high-affinity protective antibodies.